Non-invasive assessment of liver fibrosis:Can one size fit all?

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:xwp1024
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
In patients with chronic liver diseases,identification of significant liver fibrosis and cirrhosis is essential for determining treatment strategies,assessing therapeutic response,and stratifying longterm prognosis.
其他文献
Background:Male sex and advancing age are known factors associated with chronic hepatitis B disease progression and cirrhosis.However,few studies have explored the risk of the elderly women for HBV-as
会议
Background:Acute-on-chronic liver failure(AoCLF) caused by acute exacerbation of chronic hepatitis B(CHB) is a serious consequence with high mortality in China,and it is important to identify biomarke
会议
Background:Liver stiffness measurement(LSM) by Vibration Controlled Transient Elastography(VCTE) has been shown to be influenced by necro-inflammation,which leads to incorrect diagnosis of cirrhosis e
会议
Background:To determine the serological and virological characteristics of pregnant women infected with hepatitis B virus(HBV),and valuate the efficacy and safety of telbivudine(LdT) for preventing HB
会议
Background:Chronic hepatitis B virus infection leads to cirrhosis and hepatocellular carcinoma(HCC).Most risk factors associated with HCC have been identified and models have been published to predict
会议
Background:With wide use of vaccination and antiviral agents,epidemiologic characteristics of hepatitis B virus(HBV)-infected patients have changed substantially for several decades in Korea.
会议
Background:To investigated the short term efficacies of telbivudine and entecavir as first-line agents for Hepatitis B virus(HBV) suppression in patients with HBV-related advanced Hepatocellular carci
会议
Background:Hepatitis B virus is endemic in Korea with greater that 90 %infected with genotype c.Entecavir(ETV) is a potent nucleoside analogue with high genetic barrier to resistance which has been a
会议
Background:To investigate the clinical characteristics and outcome of HBV reactivation in hepatitis B surface antigen(HBsAg)-negative and hepatitis B core antibody(anti-HBc)-positive patients with hem
会议
Background:Entecavair(ETV) 1mg monotherapy was sometimes used for the chronic hepatitis B(CHB)patients with other nucleoside resistance in the past,but now,not recommended due to sequential resistance
会议